The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer
- PMID: 7780609
- DOI: 10.1016/s0960-7404(10)80027-1
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer
Abstract
Studies suggest that the interplay between matrix metalloproteinases (MMPs) and their inhibitors, tissue inhibitor of metalloproteinases (TIMPs), is an important mediator of tumour invasion and metastasis. Using immunohistochemistry, 40 specimens of colorectal cancer were examined for the presence of TIMP-1 and the MMPs, stromelysin, gelatinases A and B and interstitial collagenase. Neither enzyme nor TIMP-1 was detected in histologically normal mucosa. Within malignant tissue, stromelysin and gelatinase A were conspicuously absent in tumour cells but were immunolocalized to the extracellular matrix and for gelatinase A also to peritumoural fibroblast-like cells. Gelatinase B was confined to polymorphonuclear leucocytes. Interstitial collagenase was not identified. TIMP-1 was present in only three of the 40 tumours within the malignant stroma. These observations suggest that the mesenchymal elements of colorectal carcinomas, by acting as a source of MMPs and TIMPs, may modulate tumour invasion.
Similar articles
-
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.Surg Oncol. 1995;4(2):111-9. doi: 10.1016/s0960-7404(10)80015-5. Surg Oncol. 1995. PMID: 7551259
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.J Neurosurg. 1995 Aug;83(2):298-307. doi: 10.3171/jns.1995.83.2.0298. J Neurosurg. 1995. PMID: 7616276
-
Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients.J Periodontal Res. 1994 Mar;29(2):118-26. doi: 10.1111/j.1600-0765.1994.tb01100.x. J Periodontal Res. 1994. PMID: 8158500
-
Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.Oral Dis. 1996 Mar;2(1):70-6. doi: 10.1111/j.1601-0825.1996.tb00206.x. Oral Dis. 1996. PMID: 8957940 Review.
-
Matrix metalloproteinases and their inhibitors.Anticancer Res. 1999 Mar-Apr;19(2C):1589-92. Anticancer Res. 1999. PMID: 10365151 Review.
Cited by
-
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.Br J Cancer. 1998 Dec;78(11):1495-502. doi: 10.1038/bjc.1998.712. Br J Cancer. 1998. PMID: 9836483 Free PMC article.
-
Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.Int J Colorectal Dis. 2005 May;20(3):245-52. doi: 10.1007/s00384-004-0667-4. Epub 2004 Dec 8. Int J Colorectal Dis. 2005. PMID: 15592677
-
Matrix metalloproteinase inhibitors in the treatment of cancer.Med Oncol. 1997 Mar;14(1):1-10. doi: 10.1007/BF02990939. Med Oncol. 1997. PMID: 9232605 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous